Charlson Comorbidity Index (CCI)

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۱۲۰ • واحد: years

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
charlson assessment
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–1
  • Moderate Risk2–3
  • High Risk4–5
  • Very High Risk6–37
Direct Clinical Answer

The Charlson Comorbidity Index (CCI) calculates predicting 10-year survival in patients with multiple comorbidities. Key inputs include age. Scores guide deprescribing high-risk medications, implementing multimodal fall-prevention plans, and cognitive support. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Predicts 10-year survival in patients with multiple comorbidities. Uses 19 weighted comorbidity categories plus age adjustment to estimate mortality risk and guide clinical decision-making.

Clinical Indication

The Charlson Comorbidity Index (CCI) is indicated for bedside clinical practice to support Predicts 10-year survival in patients with multiple comorbidities. Uses 19 weighted comorbidity categories plus age adjustment to estimate mortality risk and guide clinical decision-making.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Older adults aged 65 years and older presenting with frailty syndromes, dementia, delirium, falls, and polypharmacy. Clinical application is indicated across Geriatric medicine wards, skilled nursing facilities, memory clinics, and outpatient geriatric care.

Limitations & Contraindications

Elderly patients routinely present with atypical disease manifestations, such as hypoactive delirium without fever in systemic bacteremia.

Clinical Pearls & Action Plan

Comprehensive geriatric assessment incorporating activities of daily living (ADLs) and Beers criteria medication review is essential. Guideline pearl: Helps guide treatment intensity and screening decisions based on life expectancy.

Formula & Variables:

CCI Score = Sum of comorbidity points + Age adjustment points. 10-year survival = 0.983^(CCI × 0.9)

Input Parameters

NameTypeRequiredDescription
ageintegerYesPatient age in years. Age adjustment: 0 points (<50), 1 point (50-59), 2 points (60-69), 3 points (70-79), 4 points (≥80)(years)
myocardial_infarctionstringYesHistory of myocardial infarction (1 point if present)
congestive_heart_failurestringYesCongestive heart failure (1 point if present)
peripheral_vascular_diseasestringYesPeripheral vascular disease (1 point if present)
cerebrovascular_diseasestringYesCerebrovascular accident or TIA (1 point if present)
dementiastringYesDementia (1 point if present)
chronic_pulmonary_diseasestringYesChronic pulmonary disease (1 point if present)
connective_tissue_diseasestringYesConnective tissue disease (1 point if present)
peptic_ulcer_diseasestringYesPeptic ulcer disease (1 point if present)
liver_diseasestringYesLiver disease severity. Mild (1 point), Moderate-Severe (3 points), None (0 points). Mutually exclusive with diabetes categories.
diabetesstringYesDiabetes severity. Uncomplicated (1 point), With end-organ damage (2 points), None (0 points). Mutually exclusive with liver disease categories.
hemiplegiastringYesHemiplegia (2 points if present)
moderate_severe_ckdstringYesModerate to severe chronic kidney disease (2 points if present)
localized_solid_tumorstringYesLocalized solid tumor (2 points if present)
leukemiastringYesLeukemia (2 points if present)
lymphomastringYesLymphoma (2 points if present)
metastatic_solid_tumorstringYesMetastatic solid tumor (6 points if present)
aidsstringYesAIDS (6 points if present)

Score Interpretation & Guidance

RangeStageDescription
0–1Low RiskMinimal comorbidity burden
2–3Moderate RiskModerate comorbidity burden
4–5High RiskSignificant comorbidity burden
6–37Very High RiskSevere comorbidity burden

Evidence-Based References (EBM)

  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
  • Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-51.
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-9.

Related calculators